Project Details
Description
A Phase 2b, prospective, open-label trial evaluating the efficacy, safety, and pharmacokinetics of remimazolam for intravenous sedation in paediatric patients undergoing diagnostic and/or therapeutic procedures.
| Status | Active |
|---|---|
| Effective start/end date | 8/15/21 → 8/12/24 |
Funding
- PAION
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.